Salta alla navigazione principale
Salta alla ricerca
Salta al contenuto principale
Ordina per
Keyphrases
C-reactive Protein
12%
Cardiovascular Disease
12%
Clinical Measures
12%
Clinical Outcomes
12%
Cobicistat
100%
COVID-19
87%
COVID-19 Patients
100%
Cox Proportional Hazards Model
12%
Darunavir
100%
E-value
12%
Elderly Patients
12%
High Severity
12%
Hypertension Disease
12%
In-hospital Mortality
12%
Increased Mortality
12%
Inverse Probability of Treatment Weighting
12%
Italian Hospital
12%
Italian Patients
12%
Kidney Disease
12%
Large Cohort
12%
Lopinavir
100%
Medical Records
12%
Mortality Rate
12%
Multicenter Observational Study
12%
Multinomial
12%
Non-associated
12%
Pre-existing Conditions
12%
Propensity Score
25%
Protease Inhibitors
12%
Pulmonary Disease
12%
Real-life Setting
12%
Risk of Death
12%
Therapeutic Agents
12%
Time-to-event Analysis
12%
Young Men
12%
Medicine and Dentistry
C Reactive Protein
12%
Cardiovascular Disease
12%
Cobicistat
100%
COVID-19
100%
Darunavir
100%
Darunavir Plus Ritonavir
12%
E-Value
12%
Hospital Mortality
12%
Hypertension
12%
Lopinavir/Ritonavir
100%
Medical Record
12%
Mortality Rate
12%
Nephropathy
12%
Observational Study
25%
Proportional Hazards Model
12%
Proteinase Inhibitor
12%
Silo-Filler's Disease
12%
Therapeutic Agent
12%
Nursing and Health Professions
C Reactive Protein
12%
Cardiovascular Disease
12%
Cobicistat
100%
COVID-19
100%
Darunavir
100%
Darunavir Plus Ritonavir
12%
E-Value
12%
Hospital Mortality
12%
Kidney Disease
12%
Lopinavir Plus Ritonavir
100%
Lung Disease
12%
Medical Record
12%
Mortality Rate
12%
Propensity Score
25%
Proportional Hazards Model
12%
Proteinase Inhibitor
12%
Mathematics
Cox Proportional Hazards Model
100%
Death Rate
100%
E-Value
100%
Probability
100%
Neuroscience
C-Reactive Protein
12%
Cobicistat
100%
Darunavir
100%
Lopinavir/Ritonavir
100%
Proteinase
12%
Psychology
COVID-19
100%
E-Value
12%
Kidney Disease
12%
Proportional Hazards Regression Model
12%
Study Design
12%